Glycorex Transplantation Investor Relations Material
Glycorex Transplantation AB is a Swedish biotechnology company headquartered in Uppsala. It owns GlycoMab, a patented technology used to create antibodies that are immunosuppressive drugs like Atgam, which the company produces. The company also collaborates with third-party companies for the development and commercialization of other therapies
Upcoming events for
Q2 20222022-08-26
Latest company events
Ticker symbol
GTAB
Country
Sweden
About the company
Investor Relations Page
http://www.glycorex.se/investors/?cf_page=1&cf_id=1315688405602838
Dig deeper into the Glycorex Transplantation fundamentals on Quartr.
- Skip straight to the Q&A session
- Receive notifications about new events
- Connect the financial calender on your phone
- Figure out why the stock is up or down
- Read the transcripts or scroll the deck
- Access earnings or press releases
